The focal dystonias: Current views and challenges for future research

Movement Disorders

Volumn 28, Issue 7, 2013, Pages 926-943

  Jinnah, H A ^a   Berardelli, Alfredo ^b   Comella, Cynthia ^c   Defazio, Giovanni ^d   Delong, Mahlon R ^a   Factor, Stewart ^a   Galpern, Wendy R ^e   Hallett, Mark ^e   Ludlow, Christy L ^f   Perlmutter, Joel S ^g,h   Rosen, Ami R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c RUSH MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF BARI   (Italy)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f JAMES MADISON UNIVERSITY   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h WASHINGTON UNIVERSITY   (United States)

Author keywords

Blepharospasm; Cervical dystonia; Focal dystonia; Focal hand dystonia; Spasmodic dysphonia

Indexed keywords

BOTULINUM TOXIN; BUPIVACAINE;

AIRWAY OBSTRUCTION; AXIAL DYSTONIA; BASAL GANGLION; BLEPHAROSPASM; BRAIN DEPTH STIMULATION; BREATHING DISORDER; CERVICAL DYSTONIA; CLINICAL FEATURE; DENERVATION; DIPLOPIA; DISEASE CLASSIFICATION; DRY EYE; DYSPHAGIA; FOCAL DYSTONIA; FOCAL HAND DYSTONIA; GENERALIZED DYSTONIA; GENETIC LINKAGE; HEAD DROP; HEAD MOVEMENT; HUMAN; LARYNX DISORDER; LIMB DISEASE; LIMB DYSTONIA; MEDICAL RESEARCH; MUSCLE RESECTION; NONHUMAN; OCCUPATIONAL THERAPY; ONSET AGE; OROMANDIBULAR DYSTONIA; PATHOGENESIS; PHYSIOTHERAPY; PRIORITY JOURNAL; PTOSIS; REVIEW; SEGMENTAL DYSTONIA; SEX DIFFERENCE; SIDE EFFECT; SPASMODIC DYSPHONIA; SPECTACLES; THALAMOTOMY;

EID: 84880830185     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25567     Document Type: Review

References (323)

1. Fahn S. Concept and classification of dystonia. Adv Neurol 1988;50:1-8.
2. Fahn S. The varied clinical expressions of dystonia. Neurol Clin 1984;2:541-554.
3. Fahn S. Clinical variants of idiopathic torsion dystonia. J Neurol Neurosurg Psychiatry 1989;(SUPPL.):96-100.
4. Evatt ML, Freeman A, Factor S. Adult-onset dystonia. Handb Clin Neurol 2011;100:481-511.
5. Jankovic J. Dystonic disorders. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. 5th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2007:319-347.
6. Tarsy D, Simon DK. Dystonia. N Engl J Med 2006;355:818-829.
7. Geyer HL, Bressman SB. The diagnosis of dystonia. Lancet Neurol 2006;5:780-790.
8. Defazio G, Berardelli A, Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain 2007;130:1183-1193.
9. Defazio G. Epidemiology of primary and secondary dystonia. In: Stacey ME, ed. Handbook of Dystonia. New York: Informa Healthcare USA, Inc.; 2007:11-20.
10. Adam OR, Jankovic J. Treatment of dystonia. Parkinsonism Relat Disord 2007;13(SUPPL. 3):S362-S368.
11. Jankovic J. Treatment of dystonia. Lancet Neurol 2006;5:864-872.
12. Bhidayasiri R, Tarsy D. Treatment of dystonia. Expert Rev Neurother 2006;6:863-886.
13. Albanese A, Barnes MP, Bhatia KP, et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES task force. Eur J Neurol 2006;13:433-444.
14. Fung VS, Jinnah HA, Bhatia K, Vidailhet M. Assessment of the patient with dystonia: an update on dystonia syndromes. Mov Disord 2013;28:889-898.
15. Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28:874-883.
16. Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord 1991;6:119-126.
17. Jankovic J, Leader S, Warner D, Schwartz K. Cervical dystonia: clinical findings and associated movement disorders. Neurology 1991;41:1088-1091.
18. Rondot P, Marchand MP, Dellatorlas G. Spasmodic torticollis-review of 220 patients. Can J Neurol Sci 1991;18:143-151.
19. Elble RJ. Defining dystonic tremor. Curr Neuropharmacol 2013;11:48-52.
20. Schiebler S, Schmidt A, Zittel S, et al. Arm tremor in cervical dystonia-is it a manifestation of dystonia or essential tremor? Mov Disord 2011;26:1789-1792.
21. Quinn NP, Schneider SA, Schwingenschuh P, Bhatia KP. Tremor-some controversial aspects. Mov Disord 2011;26:18-23.
22. Lalli S, Albanese A. The diagnostic challenge of primary dystonia: evidence from misdiagnosis. Mov Disord 2010;25:1619-1626.
23. Pal PK, Samii A, Schulzer M, Mak E, Tsui JK. Head tremor in cervical dystonia. Can J Neurol Sci 2000;27:137-142.
24. Deuschl G, Bain P, Brin M. Consensus statement of the movement disorder society on tremor. Mov Disord 1998;13(SUPPL. 3):2-23.
25. Rivest J, Marsden CD. Trunk and head tremor as isolated manifestations of dystonia. Mov Disord 1990;5:60-65.
26. Dauer WT, Burke RE, Greene P, Fahn S. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain 1998;121:547-560.
27. Singer C, Velickovic M. Cervical dystonia: etiology and pathophysiology. Neurol Clin 2008;26(SUPPL. 1):9-22.
28. Rivest J, Quinn N, Marsden CD. Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurology 1990;40:1571-1578.
29. Revuelta GJ, Benatar M, Freeman A, et al. Clinical subtypes of anterocollis in parkinsonian syndromes. J Neurol Sci 2011;315:100-103.
30. Hawley JS, Weiner WJ. Psychogenic dystonia and peripheral trauma. Neurology 2011;77:496-502.
31. Ibrahim NM, Martino D, van de Warrenburg BP, et al. The prognosis of fixed dystonia: a follow-up study. Parkinsonism Relat Disord 2009;15:592-597.
32. Schrag A, Trimble M, Quinn N, Bhatia K. The syndrome of fixed dystonia: an evaluation of 103 patients. Brain 2004;127:2360-2372.
33. Kabakci K, Hedrich K, Leung JC, et al. Mutations in DYT1: extension of the phenotypic and mutational spectrum. Neurology 2004;62:395-400.
34. Xiao J, Bastian RW, Perlmutter JS, et al. High-throughput mutational analysis of TOR1A in primary dystonia [serial online]. BMC Med Genet 2009;10:24.
35. LeDoux MS, Xiao J, Rudzinska M, et al. Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new cases. Parkinsonism Relat Disord 2012;18:414-425.
36. Xiao J, Uitti RJ, Zhao Y, et al. Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol 2012;71:458-469.
37. Fuchs T, Saunders-Pullman R, Masuho I, et al. Mutations in GNAL cause primary torsion dystonia. Nat Genet 2013;45:88-92.
38. Vemula SR, Puschmann A, Xiao J, et al. Role of G-α(olf) in familial and sporadic adult-onset primary dystonia [published online ahead of print March 15, 2013]. Hum Mol Genet 2013.
39. Charlesworth G, Plagnol V, Holmstrom KM, et al. Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet 2012;91:1041-1050.
40. Waddy HM, Fletcher NA, Harding AE, Marsden CD. A genetic study of idiopathic focal dystonias. Ann Neurol 1991;29:320-324.
41. Stojanovic M, Cvetkovic D, Kostic VS. A genetic study of idiopathic focal dystonias. J Neurol 1995;242:508-511.
42. Leube B, Kessler KR, Goecke T, Auburger G, Benecke R. Frequency of familial inheritance among 488 index patients with idiopathic focal dystonia and clinical variability in a large family. Mov Disord 1997;12:1000-1006.
43. Cardoso F. Drug-induced dystonia. In: Stacey MA, ed. Handbook of Dystonia. New York: Informa Healthcare, Inc.; 2008:267-276.
44. Molho ES, Feustel PJ, Factor SA. Clinical comparison of tardive and idiopathic cervical dystonia. Mov Disord 1998;13:486-489.
45. O'Riordan S, Hutchinson M. Cervical dystonia following peripheral trauma-a case-control study. J Neurol 2004;251:150-155.
46. van Rooijen DE, Geraedts EJ, Marinus J, Jankovic J, van Hilten JJ. Peripheral trauma and movement disorders: a systematic review of reported cases. J Neurol Neurosurg Psychiatry 2011;82:892-898.
47. Baizabal-Carvallo JF, Jankovic J. Movement disorders in autoimmune diseases. Mov Disord 2012;27:935-946.
48. LeDoux MS, Brady KA. Secondary cervical dystonia associated with structural lesions of the central nervous system. Mov Disord 2003;18:60-69.
49. Lohmann K, Klein C. Hereditary dystonia: what's new? What's next? Mov Disord 2013;28:899-905.
50. Neychev VK, Gross R, Lehericy S, Hess EJ, Jinnah HA. The functional neuroanatomy of dystonia. Neurobiol Dis 2011;42:185-201.
51. Zoons E, Booij J, Nederveen AJ, Dijk JM, Tijssen MA. Structural, functional and molecular imaging of the brain in primary focal dystonia-a review. Neuroimage 2011;56:1011-1020.
52. Sadnicka A, Hoffland BS, Bhatia KP, van de Warrenburg BP, Edwards MJ. The cerebellum in dystonia-help or hindrance? Clin Neurophysiol 2012;123:65-70.
53. Avanzino L, Abbruzzese G. How does the cerebellum contribute to the pathophysiology of dystonia. Basal Ganglia 2012;2:231-235.
54. Draganski B, Schneider SA, Fiorio M, et al. Genotype-phenotype interactions in primary dystonias revealed by differential changes in brain structure. Neuroimage 2009;47:1141-1147.
55. Draganski B, Thun-Hohnstein C, Bogdahn U, Windler J, May A. Motor circuit gray matter changes in idiopathic cervical dystonia. Neurology 2003;61:1228-1231.
56. Pantano P, Totaro P, Fabbrini G, et al. A transverse and longitudinal MR imaging voxel-based morphometry study in patients with primary cervical dystonia. AJNR Am J Neuroradiol 2010;32:81-84.
57. Egger K, Mueller J, Schocke M, et al. Voxel based morphometry reveals specific gray matter changes in primary dystonia. Mov Disord 2007;22:1538-1542.
58. Obermann M, Yaldizli Z, De Greiff A, et al. Morphometric changes of sensorimotor structures in focal dystonia. Mov Disord 2007;22:1117-1123.
59. Galardi G, Perani D, Grassi F, et al. Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis. Acta Neurol Scand 1996;94:172-176.
60. Magyar-Lehman S, Antonini A, Roelcke U, et al. Cerebral glucose metabolism in patients with spasmodic torticollis. Mov Disord 1997;12:704-708.
61. Naumann M, Magyar-Lehmann S, Reiners K, Erbguth F, Leenders KL. Sensory tricks in cervical dystonia: perceptual dysbalance of parietal cortex modulates frontal motor programming. Ann Neurol 2000;47:322-328.
62. Standaert DG. Update on the pathology of dystonia. Neurobiol Dis 2011;42:148-151.
63. Holton JL, Schneider SA, Ganesharajah T, et al. Neuropathology of primary adult-onset dystonia. Neurology 2008;70:695-699.
64. Prudente CN, Pardo CA, Xiao J, et al. Neuropathology of cervical dystonia. Exp Neurol 2012;241:95-104.
65. Ma K, Babij R, Cortes E, Vonsattel JP, Louis ED. Cerebellar pathology of a dual clinical diagnosis: patients with essential tremor and dystonia. Tremor Other Hyperkinet Mov 2012;2:1-6.
66. Simpson DM, Blitzer A, Brashear A, et al. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;70:1699-1706.
67. Hallett M, Benecke R, Blitzer A, Comella CL. Treatment of focal dystonias with botulinum neurotoxin. Toxicon 2009;54:628-633.
68. Jankovic J. Medical treatment of dystonia. Mov Disord 2013;28:1001-1012.
69. Brin MF, Comella CL, Jankovic J, Lai F, Naumann M. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord 2008;23:1353-1360.
70. Ruiz PJ, Castrillo JC, Burguera JA, et al. Evolution of dose and response to botulinum toxin A in cervical dystonia: a multicenter study. J Neurol 2011;258:1055-1057.
71. Skogseid IM, Kerty E. The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment. Eur J Neurol 2005;12:163-170.
72. Sethi KD, Rodriguez R, Olayinka B. Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia. J Med Econ 2012;15:419-423.
73. Waln O, Ledoux MS. Blepharospasm plus cervical dystonia with predominant anterocollis: a distinctive subphenotype of segmental craniocervical dystonia [serial online]? Tremor Other Hyperkinet Mov (N Y) 2011;2011:33, pii.
74. Glass GA, Ku S, Ostrem JL, Heath S, Larson PS. Fluoroscopic, EMG-guided injection of botulinum toxin into the longus colli for the treatment of anterocollis. Parkinsonism Relat Disord 2009;15:610-613.
75. Bhidayasiri R. Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses. Parkinsonism Relat Disord 2011;17(SUPPL. 1):S20-S24.
76. Arce CA. Selective denervation in cervical dystonia. In: Stacey MA, ed. Handbook of Dystonia. New York: Informa Healthcare USA, Inc.; 2007:381-392.
77. Perlmutter JS, Mink JW. Deep brain stimulation. Annu Rev Neurosci 2006;29:229-257.
78. Marks WJJ. Brain surgery for dystonia. In: Stacey MA, ed. Handbook of Dystonia. New York: Informa Healtcare USA, Inc.; 2007:393-406.
79. Moro E, Gross RE, Krauss JK. What's new in surgical treatments for dystonia? Mov Disord 2013;28:1013-1020.
80. Vidailhet M, Jutras MF, Grabli D, Roze E. Deep brain stimulation for dystonia. J Neurol Neurosurg Psychiatry 2012.
81. Kiss ZH, Doig-Beyaert K, Eliasziw M, Tsui J, Haffenden A, Suchowersky O. The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain 2007;130:2879-2886.
82. Limotai N, Go C, Oyama G, et al. Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical dystonia symptoms. J Neurol 2011;258:2069-2074.
83. Zetterberg L, Halvorsen K, Farnstrand C, Aquilonius SM, Lindmark B. Physiotherapy in cervical dystonia: six experimental single-case studies. Physiother Theory Pract 2008;24:275-290.
84. Boyce MJ, Canning CG, Mahant N, Morris J, Latimer J, Fung VS. Active exercise for individuals with cervical dystonia: a pilot randomized controlled trial. Clin Rehabil 2012;27:226-235.
85. Delnooz CC, Horstink MW, Tijssen MA, van de Warrenburg BP. Paramedical treatment in primary dystonia: a systematic review. Mov Disord 2009;24:2187-2198.
86. Tassorelli C, Mancini F, Balloni L, et al. Botulinum toxin and neuromotor rehabilitation: an integrated approach to idiopathic cervical dystonia. Mov Disord 2006;21:2240-2243.
87. Grandas F, Elston J, Quinn N, Marsden CD. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 1988;51:767-772.
88. Peckham EL, Lopez G, Shamim EA, et al. Clinical features of patients with blepharospasm: a report of 240 patients. Eur J Neurol 2011;18:382-386.
89. Jankovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1983;13:402-411.
90. Tolosa E, Marti MJ. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects. Adv Neurol 1988;49:73-84.
91. Conte A, Defazio G, Ferrazzano G, et al. Is increased blinking a form of blepharospasm? Neurology. In press.
92. Aramideh M, Ongerboer de Visser BW, Brans JW, Koelman JH, Speelman JD. Pretarsal application of botulinum toxin for treatment of blepharospasm. J Neurol Neurosurg Psychiatry 1995;59:309-311.
93. Inoue K, Rogers JD. Botulinum toxin injection into Riolan's muscle: somatosensory "trick." Eur Neurol 2007;58:138-141.
94. Aramideh M, Ongerboer de Visser BW, Devriese PP, Bour LJ, Speelman JD. Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm. Brain 1994;117:27-38.
95. Defazio G, Abbruzzese G, Girlanda P, Liguori R, Santoro L, Tinazzi M, Beradelli A. Phenotypic overlap in familial and sporadic primary adult-onset extracranial dystonia. J Neurol 2012;259:2414-2418.
96. Obeso JA, Gimenez-Roldan S. Clinicopathologic correlation in symptomatic dystonia. Adv Neurol 1988;50:113-122.
97. Skidmore F, Reich SG. Tardive dystonia. Curr Treat Options Neurol 2005;7:231-236.
98. Rana AQ, Kabir A, Dogu O, Patel A, Khondker S. Prevalence of blepharospasm and apraxia of eyelid opening in patients with parkinsonism, cervical dystonia and essential tremor. Eur Neurol 2012;68:318-321.
99. Defazio G, Abbruzzese G, Aniello MS, et al. Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. Neurology 2011;77:631-637.
100. Martino D, Defazio G, Alessio G, et al. Relationship between eye symptoms and blepharospasm: a multicenter case-control study. Mov Disord 2005;20:1564-1570.
101. Herz NL, Yen MT. Modulation of sensory photophobia in essential blepharospasm with chromatic lenses. Ophthalmology 2005;112:2208-2211.
102. Adams WH, Digre KB, Patel BC, Anderson RL, Warner JE, Katz BJ. The evaluation of light sensitivity in benign essential blepharospasm. Am J Ophthalmol 2006;142:82-87.
103. Digre KB, Brennan KC. Shedding light on photophobia. J Neuroophthalmol 2012;32:68-81.
104. Noseda R, Constandil L, Bourgeais L, Chalus M, Villanueva L. Changes of meningeal excitability mediated by corticotrigeminal networks: a link for the endogenous modulation of migraine pain. J Neurosci 2010;30:14420-14429.
105. Emoto H, Suzuki Y, Wakakura M, et al. Photophobia in essential blepharospasm-a positron emission tomographic study. Mov Disord 2010;25:433-439.
106. Khooshnoodi MA, Factor SA, Jinnah HA. Secondary blepharospasm associated with structural lesions of the brain. J Neurol Sci. In press.
107. Etgen T, Muhlau M, Gaser C, Sander D. Bilateral grey-matter increase in the putamen in primary blepharspasm. J Neurol Neurosurg Psychiatry 2006;77:1017-1020.
108. Horovitz SG, Ford A, Ali Najee-Ullah M, Ostuni JL, Hallett M. Anatomical correlates of blepharospasm. Transl Neurodegener 2012;1:12.
109. Dresel C, Haslinger B, Castrop F, Wohlschlaeger AM, Ceballos-Baumann AO. Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia. Brain 2006;129:36-46.
110. Schmidt KE, Linden DE, Goebel R, Zanella FE, Lanfermann H, Zubcov AA. Striatal activation during blepharospasm revealed by fMRI. Neurology 2003;60:1738-1743.
111. Kerrison JB, Lancaster JL, Zamarripa FE, et al. Positron emission tomography scanning in essential blepharospasm. Am J Ophthalmol 2003;136:846-852.
112. Suzuki Y, Mizoguchi S, Kiyosawa M, et al. Glucose hypermetabolism in the thalamus of patients with essential blepharospasm. J Neurol 2007;254:890-896.
113. Hutchinson M, Nakamura T, Moeller JR, et al. The metabolic topography of essential blepharospasm. Neurology 2000;55:673-677.
114. Perlmutter JS, Stambuk MK, Markham J, et al. Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci 1997;17:843-850.
115. Karimi M, Moerlein SM, Videen TO, et al. Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect? Mov Disord 2011;26:100-106.
116. Quartarone A, Sant'Angelo A, Battaglia F, et al. Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm. J Neurosci 2006;26:716-721.
117. Zeuner KE, Knutzen A, Al-Ali A, et al. Associative stimulation of the supraorbital nerve fails to induce timing-specific plasticity in the human blink reflex [serial online]. PLoS One 2010;5:e13602.
118. Fiorio M, Tinazzi M, Scontrini A, et al. Tactile temporal discrimination in patients with blepharospasm. J Neurol Neurosurg Psychiatry 2008;79:796-798.
119. Bradley D, Whelan R, Kimmich O, et al. Temporal discrimination thresholds in adult-onset primary torsion dystonia: an analysis by task type and by dystonia phenotype. J Neurol 2012;259:77-82.
120. Rana AQ, Shah R. Combination of blepharospasm and apraxia of eyelid opening: a condition resistant to treatment. Acta Neurol Belg 2012;112:95-96.
121. Georgescu D, Vagefi MR, McMullan TF, McCann JD, Anderson RL. Upper eyelid myectomy in blepharospasm with associated apraxia of lid opening. Am J Ophthalmol 2008;145:541-547.
122. Andrews RM, Griffiths PG, Chinnery PF, Turnbull DM. Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome. Eye (Lond) 1999;13:769-772.
123. Reese R, Gruber D, Schoenecker T, et al. Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation. Mov Disord 2011;26:691-698.
124. Weiss D, Wachter T, Breit S, et al. Involuntary eyelid closure after STN-DBS: evidence for different pathophysiological entities. J Neurol Neurosurg Psychiatry 2010;81:1002-1007.
125. Blackburn MK, Lamb RD, Digre KB, et al. FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. Ophthalmology 2009;116:997-1001.
126. Blitzer A. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Eur J Neurol 2010;17(SUPPL. 1):28-30.
127. Brin MF, Blitzer A, Stewart C. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Adv Neurol 1998;78:237-252.
128. Ludlow CL, Adler CH, Berke GS, et al. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg 2008;139:495-505.
129. Tisch SH, Brake HM, Law M, Cole IE, Darveniza P. Spasmodic dysphonia: clinical features and effects of botulinum toxin therapy in 169 patients-an Australian experience. J Clin Neurosci 2003;10:434-438.
130. Zwirner P, Dressler D, Kruse E. Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia. Eur Arch Otorhinolaryngol 1997;254:242-245.
131. Grillone GA, Blitzer A, Brin MF, Annino DJ, Saint-Hilaire MH. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A. Laryngoscope 1994;104:30-32.
132. Marion MH, Klap P, Perrin A, Cohen M. Stridor and focal laryngeal dystonia. Lancet 1992;339:457-458.
133. Chitkara A, Meyer T, Keidar A, Blitzer A. Singer's dystonia: first report of a variant of spasmodic dysphonia. Ann Otol Rhinol Laryngol 2006;115:89-92.
134. White LJ, Klein AM, Hapner ER, et al. Coprevalence of tremor with spasmodic dysphonia: a case-control study. Laryngoscope 2011;121:1752-1755.
135. Wolraich D, Vasile Marchis-Crisan C, Redding N, Khella SL, Mirza N. Laryngeal tremor: co-occurrence with other movement disorders. ORL J Otorhinolaryngol Relat Spec 2010;72:291-294.
136. Roy N. Functional dysphonia. Curr Opin Otolaryngol Head Neck Surg 2003;11:144-148.
137. Altman KW, Atkinson C, Lazarus C. Current and emerging concepts in muscle tension dysphonia: a 30-month review. J Voice 2005;19:261-267.
138. Morrison MD, Rammage LA, Belisle GM, Pullan CB, Nichol H. Muscular tension dysphonia. J Otolaryngol 1983;12:302-306.
139. Fuchs T, Gavarini S, Saunders-Pullman R, Raymond D, Erlich ME, Bressman SB, Ozelius LJ. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet 2009;41:286-288.
140. Xiao J, Zhao Y, Bastian RW, et al. Novel THAP1 sequence variants in primary dystonia. Neurology 2010;74:229-238.
141. Hersheson J, Mencacci NE, Davis M, et al. Mutations in the autoregulatory domain of beta-tubulin 4a cause hereditary dystonia [published online ahead of print December 13, 2012]. Ann Neurol 2012.
142. Wilcox RA, Winkler S, Lohmann K, Klein C. Whispering dysphonia in an Australian family (DYT4): a clinical and genetic reappraisal. Mov Disord 2011;26:2404-2408.
143. Lohmann K, Wilcox RA, Winkler S, et al. Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene [published online ahead of print December 13, 2012]. Ann Neurol 2012.
144. Schweinfurth JM, Billante M, Courey MS. Risk factors and demographics in patients with spasmodic dysphonia. Laryngoscope 2002;112:220-223.
145. Tanner K, Roy N, Merrill RM, Sauder C, Houtz DR, Smith ME. Case-control study of risk factors for spasmodic dysphonia: a comparison with other voice disorders. Laryngoscope 2012;122:1082-1092.
146. Ali SO, Thomassen M, Schulz GM, et al. Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215O PET study. J Speech Lang Hear Res 2006;49:1127-1146.
147. Haslinger B, Erhard P, Dresel C, Castrop F, Roettinger M, Ceballos-Baumann AO. "Silent event-related" fMRI reveals reduced sensorimotor activation in laryngeal dystonia. Neurology 2005;65:1562-1569.
148. Simonyan K, Ludlow CL. Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study. Cereb Cortex 2010;20:2749-2759.
149. Simonyan K, Tovar-Moll F, Ostuni J, et al. Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study. Brain 2008;131:447-459.
150. Simonyan K, Ludlow CL. Abnormal structure-function relationship in spasmodic dysphonia. Cereb Cortex 2012;22:417-425.
151. Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 1998;108:1435-1441.
152. Watts CC, Whurr R, Nye C. Botulinum toxin injections for the treatment of spasmodic dysphonia [serial online]. Cochrane Database Syst Rev 2004;3:CD004327.
153. Whurr R, Nye C, Lorch M. Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies. Int J Lang Commun Disord 1998;33(SUPPL.):327-329.
154. Truong DD, Rontal M, Rolnick M, Aronson AE, Mistura K. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope 1991;101:630-634.
155. Ludlow CL. Treatment for spasmodic dysphonia: limitations of current approaches. Curr Opin Otolaryngol Head Neck Surg 2009;17:160-165.
156. Torres-Russotto D, Perlmutter JS. Task-specific dystonias: a review. Ann N Y Acad Sci 2008;1142:179-199.
157. Altenmuller E, Baur V, Hofmann A, Lim VK, Jabusch HC. Musician's cramp as manifestation of maladaptive brain plasticity: arguments from instrumental differences. Ann N Y Acad Sci 2012;1252:259-265.
158. Conti AM, Pullman S, Frucht SJ. The hand that has forgotten its cunning-lessons from musicians' hand dystonia. Mov Disord 2008;23:1398-1406.
159. Schneider SA, Edwards MJ, Grill SE, et al. Adult-onset primary lower limb dystonia. Mov Disord 2006;21:767-771.
160. Wu LJ, Jankovic J. Runner's dystonia. Journal of the neurological sciences 2006;251(1-2):73-76.
161. Munts AG, Mugge W, Meurs TS, et al. Fixed dystonia in complex regional pain syndrome: a descriptive and computational modeling approach [serial online]. BMC Neurol 2011;11:53.
162. Quartarone A, Hallett M. Emerging concepts in the physiological basis of dystonia. Mov Disord 2013;28:958-967.
163. Leijnse JN, Hallett M. Etiological musculo-skeletal factor in focal dystonia in a musician's hand: a case study of the right hand of a guitarist. Mov Disord 2007;22:1803-1808.
164. Garraux G, Bauer A, Hanakawa T, Wu T, Kansaku K, Hallett M. Changes in brain anatomy in focal hand dystonia. Ann Neurol 2004;55:736-739.
165. Lungu C, Karp BI, Alter K, Zolbrod R, Hallett M. Long-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more. Mov Disord 2011;26:750-753.
166. Zeuner KE, Shill HA, Sohn YH, et al. Motor training as treatment in focal hand dystonia. Mov Disord 2005;20:335-341.
167. Zeuner KE, Bara-Jimenez W, Noguchi PS, Goldstein SR, Dambrosia JM, Hallett M. Sensory training for patients with focal hand dystonia. Ann Neurol 2002;51:593-598.
168. Horisawa S, Taira T, Goto S, Ochiai T, Nakajima T. Long-term improvement of musician's dystonia after stereotactic ventrooralthalamotomy [published online ahead of print March 6, 2013]. Ann Neurol 2013.
169. LeDoux MS. Meige syndrome: what's in a name? Parkinsonism Relat Disord 2009;15:483-489.
170. Thompson PD, Obeso JA, Delgado G, Gallego J, Marsden CD. Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. J Neurol Neurosurg Psychiatry 1986;49:651-656.
171. Schneider SA, Bhatia KP. The entity of jaw tremor and dystonia. Mov Disord 2007;22:1491-1495.
172. Marsden CD. Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry 1976;39:1204-1209.
173. Tan EK, Chan LL. Sensory tricks and treatment in primary lingual dystonia [letter]. Mov Disord 2005;20:388.
174. Ishii K, Tamaoka A, Shoji S. A case of primary focal lingual dystonia induced by speaking. Eur J Neurol 2001;8:507.
175. Baik JS, Park JH, Kim JY. Primary lingual dystonia induced by speaking. Mov Disord 2004;19:1251-1252.
176. Papapetropoulos S, Singer C. Primary focal lingual dystonia. Mov Disord 2006;21:429-430.
177. Esper CD, Freeman A, Factor SA. Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy. Parkinsonism Relat Disord 2010;16:438-441.
178. Charles PD, Davis TL, Shannon KM, Hook MA, Warner JS. Tongue protrusion dystonia: treatment with botulinum toxin. South Med J 1997;90:522-525.
179. Schneider SA, Aggarwal A, Bhatt MH, et al. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology 2006;67:940-943.
180. Papapetropoulos S, Singer C. Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations [serial online]. Head Face Med 2006;2:47.
181. Singer C, Papapetropoulos S. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia. Parkinsonism Relat Disord 2006;12:115-118.
182. Raudino F. Is temporomandibular dysfunction a cranial dystonia? An electrophysiological study. Headache 1994;34:471-475.
183. Frucht SJ, Fahn S, Greene PE, et al. The natural history of embouchure dystonia. Mov Disord 2001;16:899-906.
184. Bhatia KP, Quinn NP, Marsden CD. Clinical features and natural history of axial predominant adult onset primary dystonia. J Neurol Neurosurg Psychiatry 1997;63:788-791.
185. Doherty KM, van de Warrenburg BP, Peralta MC, et al. Postural deformities in Parkinson's disease. Lancet Neurol 2011;10:538-549.
186. O'Riordan S, Lynch T, Hutchinson M. Familial adolescent-onset scoliosis and later segmental dystonia in an Irish family. J Neurol 2004;251:845-848.
187. Domenech J, Tormos JM, Barrios C, Pascual-Leone A. Motor cortical hyperexcitability in idiopathic scoliosis: could focal dystonia be a subclinical etiological factor? Eur Spine J 2010;19:223-230.
188. Benecke R, Dressler D. Botulinum toxin treatment of axial and cervical dystonia. Disabil Rehabil 2007;29:1769-1777.
189. Comella CL, Shannon KM, Jaglin J. Extensor truncal dystonia: successful treatment with botulinum toxin injections. Mov Disord 1998;13:552-555.
190. Zittel S, Moll CK, Hamel W, et al. Successful GPi deep brain stimulation in a patient with adult onset primary axial dystonia. J Neurol Neurosurg Psychiatry 2009;80:811-812.
191. Soland VL, Bhatia KP, Volonte MA, Marsden CD. Focal task-specific tremors. Mov Disord 1996;11:665-670.
192. Adler CH, Edwards BW, Bansberg SF. Female predominance in spasmodic dysphonia [letter]. J Neurol Neurosurg Psychiatry 1997;63:688.
193. Konkiewitz EC, Trender-Gerhard I, Kamm C, et al. Service-based survey of dystonia in Munich. Neuroepidemiology 2002;21:202-206.
194. Warner TT. Sex-related influences on the frequency and age of onset of primary dystonia. Neurology 1999;53:1871-1873.
195. O'Riordan S, Raymond D, Lynch T, et al. Age at onset as a factor in determining the phenotype of primary torsion dystonia. Neurology 2004;63:1423-1426.
196. Weiss EM, Hershey T, Karimi M, et al. Relative risk of spread of symptoms among the focal onset primary dystonias. Mov Disord 2006;21:1175-1181.
197. Martino D, Berardelli A, Abbruzzese G, et al. Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia. Mov Disord 2012;27:1447-1450.
198. Shamim EA, Chu J, Scheider LH, Savitt J, Jinnah HA, Hallett M. Extreme task specificity in writer's cramp. Mov Disord 2011;26:2107-2109.
199. Lin PT, Hallett M. The pathophysiology of focal hand dystonia. J Hand Ther 2009;22:109-113.
200. Quartarone A, Siebner HR, Rothwell JC. Task-specific hand dystonia: can too much plasticity be bad for you? Trends Neurosci 2006;29:192-199.
201. LeDoux MS, Dauer WT, Warner T. Emerging molecular pathways for dystonia. Mov Disord 2013;28:968-981.
202. Marsden CD. The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer's cramp, and torticollis, or axial dystonia). Adv Neurol 1976;14:259-276.
203. Bhidayasiri R, Jen JC, Baloh RW. Three brothers with a very-late-onset writer's cramp. Mov Disord 2005;20:1375-1377.
204. Brancati F, Defazio G, Caputo V, et al. Novel Italian family supports clinical and genetic heterogeneity of primary adult-onset torsion dystonia. Mov Disord 2002;17:392-397.
205. Bressman SB, Warner TT, Almasy L, et al. Exclusion of the DYT1 locus in familial torticollis. Ann Neurol 1996;40:681-684.
206. Cassetta E, Del Grosso N, Bentivoglio AR, Valente EM, Frontali M, Albanese A. Italian family with cranial cervical dystonia: clinical and genetic study. Mov Disord 1999;14:820-825.
207. Defazio G, Brancati F, Valente EM, et al. Familial blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene. Mov Disord 2003;18:207-212.
208. Defazio G, Aniello MS, Masi G, Lucchese V, De Candia D, Martino D. Frequency of familial aggregation in primary adult-onset cranial cervical dystonia. Neurol Sci 2003;24:168-169.
209. Gasser T, Windgassen K, Bereznai B, Kabus C, Ludolph AC. Phenotypic expression of the DYT1 mutation: a family with writer's cramp of juvenile onset. Ann Neurol 1998;44:126-128.
210. Jimenez-Jimenez F, Martinez-Castrillo JC, Baron-Rubio M, et al. Familial focal dystonia. Eur Neurol 2002;48:232-234.
211. Leube B, Rudnicki D, Ratzlaff T, Kessler KR, Benecke R, Auburger G. Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum Mol Genet 1996;5:1673-1677.
212. Micheli S, Fernandez-Pardal M, Quesada P, Brannan T, Obeso JA. Variable onset of adult inherited focal dystonia: a problem for genetic studies. Mov Disord 1994;9:64-68.
213. Munchau A, Valente EM, Davis MB, et al. A Yorkshire family with adult-onset cranio-cervical primary torsion dystonia. Mov Disord 2000;15:954-959.
214. Norgren N, Mattson E, Forsgren L, Holmberg M. A high-penetrance form of late-onset torsion dystonia maps to a novel locus (DYT21) on chromosome 2q14.3-q21.3. Neurogenetics 2011;12:137-143.
215. Puschmann A, Xiao J, Bastian RW, Searcy JA, LeDoux MS, Wszolek ZK. An African-American family with dystonia. Parkinsonism Relat Disord 2011;17:547-550.
216. Schmidt A, Jabusch HC, Altenmuller E, et al. Dominantly transmitted focal dystonia in families of patients with musician's cramp. Neurology 2006;67:691-693.
217. Uitti RJ, Maraganore DM. Adult onset familial cervical dystonia: report of a family including monozygotic twins. Mov Disord 1993;8:489-494.
218. Winter P, Kamm C, Biskup S, et al. DYT7 gene locus for cervical dystonia on chromosome 18p is questionable. Mov Disord 2012;27:1819-1821.
219. Blanchard A, Ea V, Roubertie A, et al. DYT6 dystonia: review of the literature and creation of the UMD Locus-Specific Database (LSDB) for mutations in the THAP1 gene. Hum Mutat 2011;32:1213-1224.
220. Bonetti M, Barzaghi C, Brancati F, et al. Mutation screening of the DYT6/THAP1 gene in Italy. Mov Disord 2009;24:2424-2427.
221. Bressman SB, Raymond D, Fuchs T, Heiman GA, Ozelius LJ, Saunders-Pullman R. Mutations in THAP1 (DYT6) in early onset dystonia: a genetic screening study. Lancet Neurol 2009;8:441-446.
222. Cheng FB, Wan XH, Feng JC, Wang L, Yang YM, Cui LY. Clinical and genetic evaluation of DYT1 and DYT6 primary dystonia in China. Eur J Neurol 2011;18:497-503.
223. Cheng FB, Ozelius LJ, Wan XH, et al. THAP1/DYT6 sequence variants in non-DYT1 early-onset primary dystonia in China and their effects on RNA expression. J Neurol 2012;259:342-347.
224. Clot F, Grabli D, Burbaud P, et al. Screening of the THAP1 gene in patients with early-onset dystonia: myoclonic jerks are part of the dystonia 6 phenotype. Neurogenetics 2011;12:87-89.
225. Djarmati A, Schneider SA, Lohmann K, et al. Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study. Lancet Neurol 2009;8:447-452.
226. Dobricic VS, Kresojevic ND, Svetel MV, et al. Mutation screening of the DYT6/THAP1 gene in Serbian patients with primary dystonia. J Neurol 2013;260:1037-1042.
227. Groen JL, Ritz K, Contarino MF, et al. DYT6 dystonia: mutation screening, phenotype, and response to deep brain stimulation. Mov Disord 2010;25:2420-2427.
228. Groen JL, Yildirim E, Ritz K, et al. THAP1 mutations are infrequent in spasmodic dysphonia. Mov Disord 2011;26:1952-1954.
229. Houlden H, Schneider SA, Paudel R, et al. THAP1 mutations (DYT6) are an additional cause of early onset dystonia. Neurology 2010;74:846-850.
230. Lohmann K, Uflacker N, Erogullari A, et al. Identification and functional analysis of novel THAP1 mutations. Eur J Hum Genet 2012;20:171-175.
231. Paisan-Ruiz C, Ruiz-Martinez J, Ruibal M, et al. Identification of a novel THAP1 mutation at R29 amino-acid residue in sporadic patients with early-onset dystonia. Mov Disord 2009;24:2428-2429.
232. Sohn AS, Glockle N, Doetzer AD, et al. Prevalence of THAP1 sequence variants in German patients with primary dystonia. Mov Disord 2010;25:1982-1986.
233. Song W, Chen Y, Huang R, et al. Novel THAP1 gene mutations in patients with primary dystonia from southwest China. J Neurol Sci 2011;309:63-67.
234. Van Gerpen JA, Ledoux MS, Wszolek ZK. Adult-onset leg dystonia due to a missense mutation in THAP1. Mov Disord 2010;25:1306-1307.
235. Xiromerisiou G, Houlden H, Scarmeas N, et al. THAP1 mutations and dystonia phenotypes: genotype phenotype correlations. Mov Disord 2012;27:1290-1294.
236. Bragg DC, Armata IA, Nery FC, Breakefield XO, Sharma N. Molecular pathways in dystonia. Neurobiol Dis 2011;42:136-147.
237. Thompson VB, Jinnah HA, Hess EJ. Convergent mechanisms in etiologically diverse dystonias. Expert Opin Ther Targets 2011;15:1387-1403.
238. Jinnah HA, Hess EJ. Experimental therapeutics for dystonia. Neurotherapeutics 2008;5:198-209.
239. Perlmutter JS, Mink JW. Dysfunction of dopaminergic pathways in dystonia. Adv Neurol 2004;94:163-170.
240. Peterson DA, Sejnowski TJ, Poizner H. Convergent evidence for abnormal striatal synaptic plasticity in dystonia. Neurobiol Dis 2010;37:558-573.
241. Segawa M, Nomura Y, Nishiyama N. Dopa-responsive dystonia. In: Stacey MA, ed. Handbook of Dystonia. Yew York: Informa Healthcare, Inc.; 2008:219-244.
242. Jinnah HA, Visser JE, Harris JC, et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain 2006;129:1201-1217.
243. Visser JE, Baer PR, Jinnah HA. Lesch-Nyhan syndrome and the basal ganglia. Brain Res Rev 2000;32:449-475.
244. Tolosa E, Compta Y. Dystonia in Parkinson's disease. J Neurol 2006;253(SUPPL. 7):7-13.
245. Jankovic J, Tintner R. Dystonia and parkinsonism. Parkinsonism Rel Disord 2001;8:109-121.
246. Troiano AR, Stoessl AJ. Neuroimaging in dystonia. In: Stacey MA, ed. Handbook of Dystonia. New York: Informa Healthcare, Inc.; 2008:93-106.
247. Augood SJ, Hollingsworth Z, Albers DS, et al. Dopamine transmission in DYT1 dystonia. Adv Neurol 2004;94:53-60.
248. Boyce S, Clarke CE, Luguin R, et al. Induction of chorea and dystonia in Parkinsonian primates. Mov Disord 1990;5:3-7.
249. Perlmutter JS, Tempel LW, Black KJ, Parkinson D, Todd RD. MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia. Neurology 1997;49:1432-1438.
250. Song CH, Fan X, Exeter CJ, Hess EJ, Jinnah HA. Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia. Neurobiol Dis 2012;48:66-78.
251. Jinnah HA, Sepkuty JP, Ho T, et al. Calcium channel agonists and dystonia in the mouse. Mov Disord 2000;15:542-551.
252. Neychev V, Fan X, Mitev VI, Hess EJ, Jinnah HA. The basal ganglia and cerebellum interact in the expression of dystonic movement. Brain 2008;131:2499-2509.
253. Pizoli CE, Jinnah HA, Billingsley ML, Hess EJ. Abnormal cerebellar signaling induces dystonia in mice. J Neurosci 2002;22:7825-7833.
254. Shirley TL, Rao LM, Hess EJ, Jinnah HA. Paroxysmal dyskinesias in mice. Mov Disord 2008;23:259-264.
255. Campbell DB, Hess EJ. L-type calcium channels contribute to the tottering mouse dystonic episodes. Mol Pharmacol 1999;55:23-31.
256. Hess EJ, Jen JC, Jinnah HA. Neuronal voltage-gated calcium channels: brief overview of their function and clinical implications in neurology. Neurology 2010;75:937-938.
257. Du W, Bautista JF, Yang H, et al. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nature Genet 2005;37:733-738.
258. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995;38:571-579.
259. Nemeth AH. The genetics of primary dystonias and related disorders. Brain 2002;125:695-721.
260. Moustris A, Edwards MJ, Bhatia KP. Movement disorders and mitochondrial disease. Handb Clin Neurol 2011;100:173-192.
261. Wallace DC, Murdock DG. Mitochondria and dystonia: the movement disorder connection? Proc Natl Acad Sci U S A 1999;96:1817-1819.
262. Swerdlow RH, Wooten GF. A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndrome. Ann Neurol 2001;50:537-540.
263. Swerdlow NR, Juel VC, Wooten GF. Dystonia with and without deafness is caused by TIMM8A mutation. Adv Neurol 2004;94:147-153.
264. McFarland R, Chinnery PF, Blakely EL, et al. Homoplasmy, heteroplasmy, and mitochondrial dystonia. Neurology 2007;69:911-916.
265. Simon DK, Friedman J, Breakefield XO, et al. A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia. Neurogenetics 2003;4:199-205.
266. Kim HT, Edwards MJ, Tyson J, Quinn NP, Bintner-Glindzicz M, Bhatia KP. Blepharospasm and limb dystonia caused by Mohr-Tranebjaerg syndrome with a novel splice site mutation in the deafness/dystonia peptide gene. Mov Disord 2007;22:1328-1331.
267. Muller-Vahl KR, Kolbe H, Egensperger R, Dengler R. Mitochondriopathy, blepharospasm, and treatment with botulinum toxin. Muscle Nerve 2000;23:647-648.
268. He F, Zhang S, Qian G, Zhang C. Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid). Neurology 1995;45:2178-2183.
269. Palfi S, Leventhal L, Goetz CG, et al. Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys. Mov Disord 2000;15:524-530.
270. Schapira AH, Warner T, Gash MT, Cleeter MW, Marinho CF, Cooper JM. Complex I function in familial and sporadic dystonia. Ann Neurol 1997;41:556-559.
271. Benecke R, Strumper P, Weiss H. Electron transfer complex I defect in idiopathic dystonia. Ann Neurol 1992;32:683-686.
272. Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia. Brain 1998;121:1195-1212.
273. Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Standaert DG. The pathophysiological basis of dystonias. Nat Rev Neurosci 2008;9:222-234.
274. Hallett M. Pathophysiology of dystonia. J Neural Transm 2006;70(SUPPL.):485-488.
275. Jinnah HA, Hess EJ. A new twist on the anatomy of dystonia: the basal ganglia and the cerebellum. Neurology 2006;67:1740-1741.
276. Niethammer M, Carbon-Correll M, Argyelan M, Eidelberg D. Hereditary dystonia as a neurodevelopmental circuit disorder: evidence from neuroimaging. Neurobiol Dis 2010;42:202-209.
277. Lehericy S. A current view of the anatomic basis of dystonia. Mov Disord 2013;28:944-957.
278. Zoons E, Tijssen MAJ. Pathological changes in the brain in cervical dystonia pre- and post-mortem: a commentary with a special focus on the cerebellum [published online ahead of print April 15, 2013]. Exp Neurol 2013.
279. Schicatano EJ, Basso MA, Evinger C. Animal model explains the origins of the cranial dystonia benign essential blepharospasm. J Neurophysiol 1997;77:2842-2846.
280. Argyelan M, Carbon M, Niethammer M, et al. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci 2009;29:9740-9747.
281. Calderon DP, Fremont R, Kraenzlin F, Khodakhah K. The neural substrates of rapid-onset dystonia-parkinsonism. Nat Neurosci 2011;14:357-365.
282. Tinazzi M, Fiorio M, Fiaschi A, Rothwell JC, Bhatia KP. Sensory functions in dystonia: insights from behavioral studies. Mov Disord 2009;24:1427-1436.
283. Bradley D, Whelan R, Walsh R, et al. Temporal discrimination threshold: VBM evidence for an endophenotype in adult onset primary torsion dystonia. Brain 2009;132:2327-2335.
284. Rothwell JC, Huang YZ. Systems-level studies of movement disorders in dystonia and Parkinson's disease. Curr Opin Neurobiol 2003;13:691-695.
285. Kurian MA, Gissen P, Smith M, Heales S Jr, Clayton PT. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol 2011;10:721-733.
286. Gonzalez-Alegre P, Bode N, Davidson BL, Paulson HL. Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia. J Neurosci 2005;25:10502-10509.
287. Shaikh AG, Jinnah HA, Tripp RM, et al. Irregularity distinguishes limb tremor in cervical dystonia from essential tremor. J Neurol Neurosurg Psychiatry 2008;79:187-189.
288. Stamelou M, Edwards MJ, Hallett M, Bhatia KP. The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. Brain 2012;135:1668-1681.
289. Kuyper DJ, Parra V, Aerts S, Okun MS, Kluger BM. Nonmotor manifestations of dystonia: a systematic review. Mov Disord 2011;26:1206-1217.
290. Zurowski M, Marsh L, McDonald W. Psychiatric comorbidities in dystonia: emerging concepts. Mov Disord 2013;28:914-920.
291. Logroscino G, Livrea P, Anaclerio D, et al. Agreement among neurologists on the clinical diagnosis of dystonia at different body sites. J Neurol Neurosurg Psychiatry 2003;74:348-350.
292. Albanese A, Lalli S. Is this dystonia? Mov Disord 2009;24:1725-1731.
293. Bertram KL, Williams DP. Diagnostic delay in CD [abstract]. Mov Disord 2012;27(SUPPL. 1):S333.
294. Jog M, Chouinard S, Hobson D, et al. Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey. Can J Neurol Sci 2011;38:704-711.
295. Zoons E, Tijssen MA. Pathological changes in the brain in cervical dystonia pre- and post-mortem: a commentary with a special focus on the cerebellum [published online ahead of print April 5, 2013]. Exp Neurol 2013.
296. Draganski B, May A. Training-induced structural changes in the adult human brain. Behav Brain Res 2008;192:137-142.
297. Zatorre RJ, Fields RD, Johansen-Berg H. Plasticity in gray and white: neuroimaging changes in brain structure during learning. Nat Neurosci 2012;15:528-536.
298. van den Heuvel MP, Hulshoff Pol HE. Exploring the brain network: a review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol 2010;20:519-534.
299. Song CH, Bernhard D, Bolarinwa C, Hess EJ, Smith Y, Jinnah HA. Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of dystonia. Neurobiol Dis 2013;54:362-371.
300. Zhang L, Yokoi F, Jin YH, et al. Altered dendritic morphology of Purkinje cells in Dyt1 DeltaGAG knock-in and purkinje cell-specific Dyt1 conditional knockout mice [serial online]. PLoS One 2011;6:e18357.
301. Oleas J, Yokoi F, MP D, Pisani A, Li Y. Engineering animal models for dystonia: what have we learned? Mov Disord 2013;28:990-1000.
302. Jinnah HA, Hess EJ, LeDoux MS, Sharma N, Baxter MG, DeLong MR. Rodent models for dystonia research: characteristics, evaluation, and utility. Mov Disord 2005;20:283-292.
303. Wilson BK, Hess EJ. Animal models of dystonia. Mov Disord 2013;28:982-989.
304. Jinnah HA, Richter A, Mink JW, et al. Animal models for drug discovery in dystonia. Expert Opin Drug Discov 2008;3:83-97.
305. Raike RS, Pizoli CE, Weisz C, van den Maagdenberg AM, Jinnah HA, Hess EJ. Limited regional cerebellar dysfunction induces focal dystonia in mice. Neurobiol Dis 2012;49C:200-210.
306. Nakazawa M, Kobayashi T, Matsuno K, Mita S. Possible involvement of a sigma receptor subtype in the neck dystonia in rats. Pharmacol Biochem Behav 1999;62:123-126.
307. Klier EM, Wang H, Constantin AG, Crawford JD. Midbrain control of three-dimensional head orientation. Science 2002;295:1314-1316.
308. Holmes AL, Forcelli PA, DesJardin JT, et al. Superior colliculus mediates cervical dystonia evoked by inhibition of the substantia nigra pars reticulata. J Neurosci 2012;32:13326-13332.
309. Guehl D, Cuny E, Ghorayeb I, Michelet T, Bioulac B, Burbaud P. Primate models of dystonia. Prog Neurobiol 2009;87:118-131.
310. Perlmutter JS, Thach WT. Writer's cramp: questions of causation. Neurology 2007;69:331-332.
311. Popa T, Velayudhan B, Hubsch C, et al. Cerebellar processing of sensory inputs primes motor cortex plasticity. Cereb Cortex 2013;23:305-314.
312. Espay AJ, Morgante F, Purzner J, Gunraj CA, Lang AE, Chen R. Cortical and spinal abnormalities in psychogenic dystonia. Ann Neurol 2006;59:825-834.
313. Martino D, Liuzzi D, Macerollo A, Aniello MS, Livrea P, Defazio G. The phenomenology of the geste antagoniste in primary blepharospasm and cervical dystonia. Mov Disord 2010;25:407-412.
314. Cao S, Hewett JW, Yokoi F, et al. Chemical enhancement of torsinA function in cell and animal models of torsion dystonia. Dis Model Mech 2010;3:386-396.
315. Hewett JW, Tannous B, Niland BP, et al. Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc Natl Acad Sci USA 2007;104:7271-7276.
316. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord 2005;20(SUPPL. 11):S11-S16.
317. Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T. Rating scales for dystonia: a multicenter trial. Mov Disord 2003;18:303-312.
318. Wabbels B, Jost WH, Roggenkamper P. Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm. J Neural Transm 2011;118:925-943.
319. Pekmezovic T, Svetel M, Ivanovic N, et al. Quality of life in patients with focal dystonia. Clin Neurol Neurosurg 2009;111:161-164.
320. Slawek J, Friedman A, Potulska A, et al. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections. Funct Neurol 2007;22:95-100.
321. Hall TA, McGwin G Jr, Searcey K, et al. Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm. Arch Ophthalmol 2006;124:116-119.
322. Kupsch A, Benecke R, Muller J, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006;355:1978-1990.
323. Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005;352:459-467.